drugset / Trial / NCT02504125

The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty

NCT02504125 ↗

Phase 4 Completed 120 enrolled Xijing Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized, double-blind, single-center and controlled study comparing the efficacy and safety of intravenous administration of tranexamic acid to reduce blood loss in simultaneous bilateral total knee arthroplasty.

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.